US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 4.250
  • +0.240+5.99%
Close Nov 22 16:00 ET
  • 4.033
  • -0.217-5.11%
Post 20:01 ET
300.00MMarket Cap-2485P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C4 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 3.600M--
--2024/Q315.362M / 4.600M--
--2024/Q212.006M / 4.783M--
--2024/Q13.039M / 9.283M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 3.600M--
--2024/Q315.362M / 4.600M--
--2024/Q212.006M / 4.783M--
--2024/Q13.039M / 9.283M--

Unlock Free Earnings Estimates

C4 Therapeutics Earnings Reports

  • C4 Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 31 07:15 ET

  • C4 Therapeutics | 8-K: C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Oct 31 07:11 ET

  • C4 Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:31 ET

  • C4 Therapeutics | 8-K: C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 1 07:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data